BenevolentAI
VerifiedBenevolentAI is a leading, clinical-stage AI-enabled drug discovery company.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$35m (Public information from May 2024)
Share price
€0.62 BAI.AS
Company register number 09781806
London England (HQ)
No columns specified